Company News
Alamar Biosciences IPO Targets $159M Top
Alamar Biosciences plans to sell ~9.375 million shares at $15‑$17 each, potentially raising just over $159 million.
Investor demand exceeds 10 times the supply, driven by long‑only and health‑care foc